To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.
Non- muscle invasive bladder cancer (NMIBC) is a heterogeneous group of cancers. For most urologists the treatment of T1G3 tumor poses a dilemma of management.The spectrum of clinical behavior includes; T1 lesions that will not progress however T1G3 may be potentially lethal, associated with metastatic disease at the time of presentation. The major goal of treatment for T1G3 BC should be bladder preservation whenever possible. Intravesical therapy with Bacille Calmette Guerin (BCG) may decrease the recurrence rate by compared with transurethral resection of bladder tumor (TURBT) alone.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
chemoradiation in case of T1G3 BC after BCG failure.
Result of chemoradiation for recurrentT1G3 BC after BCG failure
treatment of 20 patients with recurrent T1G3 BC by chemoradiation to see efficacy and safety .and to reduce the number of recurrent cases and improve survival.
Time frame: followup within two years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.